MedTrace Logo

Valproic Acid-associated Hypoalbuminemia in Medically Fragile Patients

NCT00723762 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2011-03-10

No results posted yet for this study

Summary

The purpose of this study is to investigate potential mechanisms of valproic acid-associated low serum albumin in medically fragile pediatric and young adult epileptic patients of a long-term care facility.

Conditions

Interventions

PROCEDURE

Specimen collection

A blood sample and a spot urine sample will be obtained from all eligible patients receiving VPA at the start of the study.

Sponsors & Collaborators

  • Akron Children's Hospital

    lead OTHER

Principal Investigators

  • Michael Reed, PharmD · Akron Children's Hospital Research Center

  • Martha Blackford, PharmD · Akron Children's Hospital

  • Richard Grossberg, MD · Hattie Larlham

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2009-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00723762 on ClinicalTrials.gov